About Torax Medical
Torax Medical is a Healthcare company based in Minneapolis (United States) founded in 2002, and was acquired by Ethicon in February 2017. Products to restore human sphincter function. Torax Medical has raised $102.7 million across 8 funding rounds from investors including Piper Jaffray, Johnson & Johnson Innovation – JJDC and Sanderling Ventures. The company has 70 employees. The company was acqui-hired. Its focus areas include Life Sciences, Gastroenterology, Medical Devices and Therapeutic Devices. Its legal entity is Torax Medical Inc. Its competitors include HyGIeaCare, Lexington Medical and OverStitch; 2 of its 3 listed competitors have raised funding.
Company details
Torax Medical, a clinical stage medical device company, has developed a platform technology Magnetic Sphincter Augmentation (MSA). It uses magnetic force to augment weak defective sphincter muscles. Has two products - Linx (for the treatment of gastroesophageal reflux disease) and Fenix (to treat fecal incontinence). Linx is commercially available. Fenix is CE Marked, but not approved in the US.
- Headquarters Minneapolis, United States
- Employees 70
- Stage Acquired
- SectorsHealthcare
- Website toraxmedical.com
- Social LinkedIn Facebook
- Acquired by Ethicon (Feb 2017)
- Legal Name Torax Medical Inc
- Total Equity Funding$102.7M (USD)
in 8 rounds
- Latest Funding Round$25M (USD), Series E
Jul 2016
- InvestorsPiper Jaffray
& 7 more
- Employee Count70
- Acquired byEthicon
(Feb 2017)
Funding Insights of Torax Medical
Torax Medical has successfully raised a total of $102.7M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $25 million completed in July 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $102.7M
- Total Rounds 8
- Last Round Series E — $25M
- First Round $2M
(Feb 2004)
- Investors Count 7
All 8 funding rounds of Torax Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2016 | $25M | Series E | – | Johnson & Johnson Innovation – JJDC | |
| Dec 2013 | $13.7M | Series D | – | – | – |
| Sep 2012 | $30M | Series D | – | Piper Jaffray | |
| Aug 2012 | $3M | Series C | – | – | – |
| May 2011 | $4M | Series C | – | – | – |
| Apr 2009 | $15M | Series C | – | – | – |
| Jun 2005 | $10M | Series B | – | Thomas, McNerney & Partners, Sanderling Ventures | – |
| Feb 2004 | $2M | Series A | – | – | – |
8 investors in total: 8 institutional.
Investors in Torax Medical
Torax Medical has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Piper Jaffray, Johnson & Johnson Innovation – JJDC and Sanderling Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm backed by Johnson & Johnson | jnjinnovation.com/jjdc | Cambridge, United States | ||
Biomedical investment financing and active management services. | sanderling.com | |||
| tm-partners.com | ||||
Early-stage US healthcare investments are made by Accuitive Medical Ventures. | amvpartners.com | Duluth, United States | ||
Tech and Life Sciences focused corporate VC firm investing in the US | kpventures.com | Oakland, United States | ||
Healthcare startups are accelerated by Mayo Clinic Business Accelerator. | mcbusaccel.com | Rochester, United States | ||
Middle market focused investment bank | 1895 | piperjaffray.com | Minneapolis, United States | |
Specializes in surgical sutures and wound closure devices. | 1886 | ethicon.com | Cincinnati, United States |
Investor details for Torax Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Torax Medical
4 dated milestones of Torax Medical across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Torax Medical is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Series E, of $25.0M.
- Exit Acquired by Ethicon.
Competitors of Torax Medical
Torax Medical has 3 listed competitors in our database, 2 of them funded. They include HyGIeaCare, Lexington Medical and OverStitch.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hygieacare.com | 2014 | Austin, United States | $16.3M | Provides a specialized device for effective colonoscopy preparation. | ||
| lexington-med.com | 2013 | Watertown, United States | $37.79M | Abdominal surgical instruments are developed for medical procedures. | ||
| overstitch.com | 2013 | Austin, United States | 132 | Offers comprehensive therapy solutions for endoscopic suturing. |
Detailed competitors of Torax Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Torax Medical
Websites that share an audience with Torax Medical (toraxmedical.com).
Websites whose visitors overlap most with Torax Medical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
starpoli.com | starpoli.com | 100% | #6,323,429 | – | |
| endogastricsolutions.com | 99% | 1.1K | #12,322,852 | View details | |
gerdhelp.com | gerdhelp.com | 63% | #970,242 | – | |
refluxdefense.com | refluxdefense.com | 62% | – | ||
refluxrepair.com | refluxrepair.com | 62% | – |
Top companies in Gastroenterology
3 companies that operate in the same segment as Torax Medical (Gastroenterology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | 411 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Torax Medical
Complete news archive for Torax Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Torax Medical
Torax Medical was founded in 2002 and raised its 1st funding round 2 years after it was founded.
Torax Medical is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Torax Medical is a funded company, having raised a total of $102.7M across 8 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Feb 2004.
Torax Medical has 70 employees.
Torax Medical, a clinical stage medical device company, has developed a platform technology Magnetic Sphincter Augmentation (MSA). It uses magnetic force to augment weak defective sphincter muscles. Has two products - Linx (for the treatment of gastroesophageal reflux disease) and Fenix (to treat fecal incontinence). Linx is commercially available. Fenix is CE Marked, but not approved in the US.
Torax Medical's top competitors include Lexington Medical, HyGIeaCare and OverStitch.
Torax Medical has 8 investors. Key investors include Piper Jaffray, Johnson & Johnson Innovation – JJDC, Sanderling Ventures, Thomas, McNerney & Partners, and Accuitive Medical Ventures.
Torax Medical operates through Torax Medical Inc.
Yes. Torax Medical was acquired by Ethicon in February 2017.